Pershing Edward
Insider CIK 1689739 · PVCT CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-30 | 2026-10-30 | 24,544 | — | $0 | 3,030,677 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-30 | 2026-10-30 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-23 | 2026-10-23 | 7,599 | — | $0 | 3,006,133 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-23 | 2026-10-23 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-10 | 2026-10-13 | 22,609 | — | $0 | 2,998,534 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-10 | 2026-10-13 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-03 | 2026-10-05 | 13,216 | — | $0 | 2,975,925 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-10-03 | 2026-10-05 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-18 | 2026-09-18 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-18 | 2026-09-18 | 13,216 | — | $0 | 2,962,709 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-18 | 2026-09-18 | 13,216 | — | $0 | 2,962,709 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-18 | 2026-09-18 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-11 | 2026-09-11 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-11 | 2026-09-11 | 13,216 | — | $0 | 2,949,493 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-11 | 2026-09-11 | 13,216 | — | $0 | 2,949,493 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-11 | 2026-09-11 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-04 | 2026-09-08 | 11,328 | — | $0 | 2,936,277 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-04 | 2026-09-08 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-04 | 2026-09-08 | 11,328 | — | $0 | 2,936,277 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-09-04 | 2026-09-08 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-08-26 | 2026-08-26 | 11,328 | — | $0 | 2,924,949 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-08-26 | 2026-08-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-08-26 | 2026-08-26 | 11,328 | — | $0 | 2,924,949 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-08-26 | 2026-08-26 | — | — | — | — | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-06-30 | 2026-07-02 | 45,860 | — | $0 | 2,866,761 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-06-05 | 2026-06-05 | 9,436 | — | $0 | 2,857,285 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-06-05 | 2026-06-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-05-28 | 2026-05-29 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-23 | 2026-05-26 | 32,089 | — | $0 | 2,847,849 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-23 | 2026-05-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-15 | 2026-05-15 | 22,651 | — | $0 | 2,815,760 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-15 | 2026-05-15 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-07 | 2026-05-07 | 18,876 | — | $0 | 2,793,109 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-05-07 | 2026-05-07 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-04-29 | 2026-04-29 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-04-29 | 2026-04-29 | 30,202 | — | $0 | 2,774,233 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-04-04 | 2026-04-06 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-04-04 | 2026-04-06 | 33,977 | — | $0 | 2,744,031 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-03-25 | 2026-03-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-03-20 | 2026-03-20 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-03-20 | 2026-03-20 | 49,067 | — | $0 | 2,710,054 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-03-12 | 2026-03-16 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-03-05 | 2026-03-06 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-02-26 | 2026-02-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-02-20 | 2026-02-23 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-02-20 | 2026-02-23 | 47,180 | — | $0 | 2,660,987 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-02-19 | 2026-02-23 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-02-12 | 2026-02-17 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | P Buy deriv | 2026-02-09 | 2026-02-11 | 34,940 | $2.86 | $99.9K | 2,613,807 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-02-05 | 2026-02-09 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-01-30 | 2026-02-02 | 37,744 | — | $0 | 2,578,867 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-01-30 | 2026-02-02 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2026-01-28 | 2026-01-29 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-01-16 | 2026-01-16 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2026-01-16 | 2026-01-16 | 37,744 | — | $0 | 2,541,123 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-12-11 | 2025-12-15 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-12-05 | 2025-12-08 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-11-26 | 2025-11-28 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-11-20 | 2025-11-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-11-13 | 2025-11-14 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-11-06 | 2025-11-07 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-10-30 | 2025-10-31 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-10-23 | 2025-10-24 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-10-16 | 2025-10-17 | 18,880 | — | $0 | 2,503,379 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-10-16 | 2025-10-17 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-10-10 | 2025-10-14 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-10-03 | 2025-10-09 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-09-30 | 2025-09-30 | 66,052 | — | $0 | 2,484,499 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-09-30 | 2025-09-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-09-19 | 2025-09-19 | 37,760 | — | $0 | 2,418,447 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-09-19 | 2025-09-19 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-09-18 | 2025-09-19 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-09-11 | 2025-09-12 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-09-04 | 2025-09-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-29 | 2025-08-29 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-29 | 2025-08-29 | 28,320 | — | $0 | 2,380,687 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-08-26 | 2025-08-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-22 | 2025-08-22 | 37,760 | — | $0 | 2,352,367 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-22 | 2025-08-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-08 | 2025-08-12 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-08-08 | 2025-08-12 | 18,880 | — | $0 | 2,314,607 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-07-18 | 2025-07-21 | 62,303 | — | $0 | 2,295,727 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-07-18 | 2025-07-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-06-26 | 2025-06-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-06-26 | 2025-06-26 | 122,692 | — | $0 | 2,233,424 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-06-20 | 2025-06-23 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-06-20 | 2025-06-23 | 18,880 | — | $0 | 2,110,732 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-06-05 | 2025-06-06 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-05-23 | 2025-05-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-05-15 | 2025-05-15 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-05-07 | 2025-05-08 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-04-29 | 2025-04-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-29 | 2025-05-02 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-29 | 2025-05-02 | 18,876 | — | $0 | 2,091,852 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-19 | 2025-04-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-19 | 2025-04-21 | 9,438 | — | $0 | 2,072,976 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-11 | 2025-04-16 | 7,551 | — | $0 | 2,063,538 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-04-11 | 2025-04-16 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-04-04 | 2025-04-08 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-03-26 | 2025-03-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-03-26 | 2025-03-26 | 150,975 | — | $0 | 2,055,987 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-03-21 | 2025-03-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-03-21 | 2025-03-21 | 9,436 | — | $0 | 1,905,012 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-03-20 | 2025-03-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-02-27 | 2025-02-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-02-27 | 2025-02-27 | 67,953 | — | $0 | 1,895,576 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-02-20 | 2025-02-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-02-15 | 2025-02-19 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-02-15 | 2025-02-19 | 27,989 | — | $0 | 1,827,623 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-01-30 | 2025-01-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2025-01-30 | 2025-01-30 | 51,290 | — | $0 | 1,799,634 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-01-30 | 2025-01-31 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2025-01-16 | 2025-01-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-12-28 | 2025-01-08 | 37,760 | — | $0 | 1,748,344 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-12-28 | 2025-01-08 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-12-02 | 2024-12-04 | 25,470,215 | — | $0 | 25,470,215 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-11-29 | 2024-12-02 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-11-29 | 2024-12-02 | 18,880 | — | $0 | 1,710,584 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | P Buy deriv | 2024-11-22 | 2024-11-25 | 80,365 | $2.86 | $229.8K | 1,691,704 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-10-16 | 2024-10-17 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-09-30 | 2024-09-30 | 168,367 | — | $0 | 1,611,339 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-09-30 | 2024-09-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-09-19 | 2024-09-20 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-08-29 | 2024-08-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-08-22 | 2024-08-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-08-08 | 2024-08-09 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-08-03 | 2024-08-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-08-03 | 2024-08-05 | 28,320 | — | $0 | 1,442,972 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-07-20 | 2024-07-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-07-20 | 2024-07-22 | 47,199 | — | $0 | 1,414,652 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-07-18 | 2024-07-19 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-06-30 | 2024-07-01 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-06-30 | 2024-07-01 | 47,180 | — | $0 | 1,367,453 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-06-26 | 2024-07-02 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-06-20 | 2024-06-21 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-06-15 | 2024-06-17 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-06-15 | 2024-06-17 | 47,190 | — | $0 | 1,320,273 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-05-26 | 2024-05-28 | 18,876 | — | $0 | 1,273,083 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-05-26 | 2024-05-28 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-05-12 | 2024-05-13 | 75,503 | — | $0 | 1,254,207 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-05-12 | 2024-05-13 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-04-29 | 2024-04-30 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-04-25 | 2024-04-26 | 37,752 | — | $0 | 1,178,704 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-04-25 | 2024-04-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-04-19 | 2024-04-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-04-11 | 2024-04-15 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-04-06 | 2024-04-09 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-04-06 | 2024-04-09 | 47,190 | — | $0 | 1,140,952 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-03-26 | 2024-03-26 | 0 | $400000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-03-21 | 2024-03-22 | 0 | $25000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-03-17 | 2024-03-18 | 47,190 | — | $0 | 1,093,762 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-03-17 | 2024-03-18 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-02-27 | 2024-02-28 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-02-27 | 2024-02-28 | 37,744 | — | $0 | 1,046,572 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-02-27 | 2024-02-28 | 0 | $180000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-02-17 | 2024-02-20 | 47,180 | — | $0 | 1,008,828 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-02-17 | 2024-02-20 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-02-15 | 2024-02-16 | 0 | $75000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2024-01-30 | 2024-02-01 | 0 | $135000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-01-26 | 2024-01-29 | 47,180 | — | $0 | 961,648 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-01-26 | 2024-01-29 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-01-12 | 2024-01-12 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2024-01-12 | 2024-01-12 | 47,180 | — | $0 | 914,468 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-12-28 | 2023-12-29 | 0 | $100000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-22 | 2023-12-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-22 | 2023-12-22 | 9,440 | — | $0 | 876,728 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-19 | 2023-12-20 | 37,760 | — | $0 | 867,288 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-19 | 2023-12-20 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-02 | 2023-12-04 | 56,628 | — | $0 | 829,528 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-12-02 | 2023-12-04 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-11-29 | 2023-11-30 | 0 | $50000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-15 | 2023-11-15 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-15 | 2023-11-15 | 9,440 | — | $0 | 772,920 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-08 | 2023-11-13 | 37,744 | — | $0 | 763,480 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-08 | 2023-11-13 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-01 | 2023-11-01 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-11-01 | 2023-11-01 | 13,216 | — | $0 | 725,736 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-10-27 | 2023-10-27 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-10-27 | 2023-10-27 | 2,832 | — | $0 | 712,520 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-10-14 | 2023-10-19 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-10-14 | 2023-10-19 | 18,888 | — | $0 | 709,688 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | P Buy deriv | 2023-10-03 | 2023-10-19 | 19,311 | $2.86 | $55.2K | 690,800 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-30 | 2023-10-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-30 | 2023-10-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-23 | 2023-10-05 | 41,518 | — | $0 | 671,489 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-23 | 2023-10-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-01 | 2023-10-05 | 28,320 | — | $0 | 629,971 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-09-01 | 2023-10-05 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-08-03 | 2023-08-04 | 0 | $75000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-07-28 | 2023-07-28 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-07-28 | 2023-07-28 | 28,326 | — | $0 | 563,891 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-07-24 | 2023-07-26 | 56,639 | — | $0 | 535,565 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2023-07-24 | 2023-07-26 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-07-20 | 2023-07-24 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-06-30 | 2023-07-05 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-06-15 | 2023-06-16 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-05-26 | 2023-05-30 | 0 | $50000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-05-12 | 2023-05-15 | 0 | $200000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-04-25 | 2023-04-26 | 0 | $100000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-04-06 | 2023-04-10 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-03-17 | 2023-03-21 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-02-27 | 2023-03-21 | 0 | $100000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-02-17 | 2023-02-22 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-01-26 | 2023-01-30 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2023-01-12 | 2023-01-12 | 0 | $125000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-12-22 | 2023-01-12 | 0 | $25000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-12-19 | 2023-01-12 | 0 | $100000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-12-02 | 2022-12-05 | 0 | $150000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-11-15 | 2022-11-17 | 0 | $25000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-11-08 | 2022-11-15 | 0 | $100000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-11-01 | 2022-11-02 | 0 | $35000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-10-27 | 2022-10-28 | 0 | $7500.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-10-14 | 2022-10-28 | 0 | $50000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-09-30 | 2022-10-28 | 0 | $110000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-09-23 | 2022-10-28 | 0 | $75000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-09-01 | 2023-10-05 | 37,760 | $100000.00 | $3.78B | 601,651 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-07-27 | 2022-08-12 | 0 | $75000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2022-07-15 | 2022-08-12 | 0 | $150000.00 | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2021-06-20 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | M Exercise deriv | 2021-06-20 | 2021-06-22 | 0 | — | $0 | 478,926 | SEC↗ |
| PVCT PROVECTUS BIOPHARMACEUTICA | A Award deriv | 2021-06-17 | 2021-06-22 | 478,926 | — | $0 | 0 | SEC↗ |